Immunoglobulin A nephropathy could be a clue for the recurrence of gastric adenocarcinoma.
Ismail
I
Kocyigit
Sumeyra
S
Dortdudak
Eray
E
Eroglu
Aydin
A
Unal
Murat H
MH
Sipahioglu
Veli
V
Berk
Bulent
B
Tokgoz
Oktay
O
Oymak
D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary*; D059248:Chemoradiotherapy; D003131:Combined Modality Therapy; D004487:Edema / Q000209:etiology; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000209:etiology*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D019808:Losartan / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009367:Neoplasm Staging; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000188:drug therapy / Q000209:etiology*; D013274:Stomach Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000601:surgery / Q000628:therapy
D019808:Losartan; D008775:Methylprednisolone